Sensitivity of the SNNOOP10 list in the high-risk secondary headache detection

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Sensitivity of the SNNOOP10 list in the high-risk secondary headache detection. / García-Azorín, David; Abelaira-Freire, Jaime; González-García, Nuria; Rodriguez-Adrada, Esther; Schytz, Henrik Winther; Barloese, Mads; Guerrero, Ángel Luis; Porta-Etessam, Jesús; Martín-Sánchez, Francisco Javier.

In: Cephalalgia, Vol. 42, No. 14, 2022, p. 1521-1531.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

García-Azorín, D, Abelaira-Freire, J, González-García, N, Rodriguez-Adrada, E, Schytz, HW, Barloese, M, Guerrero, ÁL, Porta-Etessam, J & Martín-Sánchez, FJ 2022, 'Sensitivity of the SNNOOP10 list in the high-risk secondary headache detection', Cephalalgia, vol. 42, no. 14, pp. 1521-1531. https://doi.org/10.1177/03331024221120249

APA

García-Azorín, D., Abelaira-Freire, J., González-García, N., Rodriguez-Adrada, E., Schytz, H. W., Barloese, M., Guerrero, Á. L., Porta-Etessam, J., & Martín-Sánchez, F. J. (2022). Sensitivity of the SNNOOP10 list in the high-risk secondary headache detection. Cephalalgia, 42(14), 1521-1531. https://doi.org/10.1177/03331024221120249

Vancouver

García-Azorín D, Abelaira-Freire J, González-García N, Rodriguez-Adrada E, Schytz HW, Barloese M et al. Sensitivity of the SNNOOP10 list in the high-risk secondary headache detection. Cephalalgia. 2022;42(14):1521-1531. https://doi.org/10.1177/03331024221120249

Author

García-Azorín, David ; Abelaira-Freire, Jaime ; González-García, Nuria ; Rodriguez-Adrada, Esther ; Schytz, Henrik Winther ; Barloese, Mads ; Guerrero, Ángel Luis ; Porta-Etessam, Jesús ; Martín-Sánchez, Francisco Javier. / Sensitivity of the SNNOOP10 list in the high-risk secondary headache detection. In: Cephalalgia. 2022 ; Vol. 42, No. 14. pp. 1521-1531.

Bibtex

@article{be66795f9cae4e2b9542aea7cd70cf45,
title = "Sensitivity of the SNNOOP10 list in the high-risk secondary headache detection",
abstract = "Aim: To evaluate the diagnostic accuracy of the SNNOOP10 list in the detection of high-risk headaches. Methods: Patients that visited the Hospital Cl{\'i}nico San Carlos (Madrid) emergency department due to headache that were allocated to a Manchester Triage System level between critical and urgent were prospectively included but retrospectively analysed. A researcher blind to the patients{\textquoteright} diagnosis administered a standardised questionnaire and afterwards a neurologist blind to the questionnaire results diagnosed the patient according to the International Classification of Headache Disorders. The primary endpoint was to assess the sensitivity of the SNNOOP10 list in the detection of high-risk headaches. Secondary endpoints included the evaluation of the sensitivity, specificity, positive predictive value, negative predictive value and area under the curve of each SNNOOP10 item. Results: Between April 2015 and October 2021, 100 patients were included. Patients were 44 years old (inter-quartile range: 33.6–64.7) and 57% were female. We identified 37 different diagnoses. Final diagnosis was a primary headache in 33%, secondary headache in 65% and cranial neuralgia in 2%. There were 46 patients that were considered as having high-risk headache. Patients from the primary headache group were younger and more frequently female. Sensitivity of SNNOOP10 list was 100% (95% confidence interval: 90.2%–100%). The items with higher sensitivity were neurologic deficit or disfunction (75.5%), pattern change or recent onset of the headache (64.4%), onset after 50 years (64.4%). The most specific items were posttraumatic onset of headache (94.5%), neoplasm in history (89.1%) and systemic symptoms (89%). The area under the curve of the SNNOOP10 list was 0.66 (95% CI: 0.55–0.76). Conclusion: The red flags from the SNNOOP10 list showed a 100% sensitivity in the detection of high-risk headache disorders.",
keywords = "cerebrovascular disorders, diagnosis, emergency service, Headache disorders, hospital, neoplasms, secondary",
author = "David Garc{\'i}a-Azor{\'i}n and Jaime Abelaira-Freire and Nuria Gonz{\'a}lez-Garc{\'i}a and Esther Rodriguez-Adrada and Schytz, {Henrik Winther} and Mads Barloese and Guerrero, {{\'A}ngel Luis} and Jes{\'u}s Porta-Etessam and Mart{\'i}n-S{\'a}nchez, {Francisco Javier}",
note = "Publisher Copyright: {\textcopyright} International Headache Society 2022.",
year = "2022",
doi = "10.1177/03331024221120249",
language = "English",
volume = "42",
pages = "1521--1531",
journal = "Cephalalgia",
issn = "0800-1952",
publisher = "SAGE Publications",
number = "14",

}

RIS

TY - JOUR

T1 - Sensitivity of the SNNOOP10 list in the high-risk secondary headache detection

AU - García-Azorín, David

AU - Abelaira-Freire, Jaime

AU - González-García, Nuria

AU - Rodriguez-Adrada, Esther

AU - Schytz, Henrik Winther

AU - Barloese, Mads

AU - Guerrero, Ángel Luis

AU - Porta-Etessam, Jesús

AU - Martín-Sánchez, Francisco Javier

N1 - Publisher Copyright: © International Headache Society 2022.

PY - 2022

Y1 - 2022

N2 - Aim: To evaluate the diagnostic accuracy of the SNNOOP10 list in the detection of high-risk headaches. Methods: Patients that visited the Hospital Clínico San Carlos (Madrid) emergency department due to headache that were allocated to a Manchester Triage System level between critical and urgent were prospectively included but retrospectively analysed. A researcher blind to the patients’ diagnosis administered a standardised questionnaire and afterwards a neurologist blind to the questionnaire results diagnosed the patient according to the International Classification of Headache Disorders. The primary endpoint was to assess the sensitivity of the SNNOOP10 list in the detection of high-risk headaches. Secondary endpoints included the evaluation of the sensitivity, specificity, positive predictive value, negative predictive value and area under the curve of each SNNOOP10 item. Results: Between April 2015 and October 2021, 100 patients were included. Patients were 44 years old (inter-quartile range: 33.6–64.7) and 57% were female. We identified 37 different diagnoses. Final diagnosis was a primary headache in 33%, secondary headache in 65% and cranial neuralgia in 2%. There were 46 patients that were considered as having high-risk headache. Patients from the primary headache group were younger and more frequently female. Sensitivity of SNNOOP10 list was 100% (95% confidence interval: 90.2%–100%). The items with higher sensitivity were neurologic deficit or disfunction (75.5%), pattern change or recent onset of the headache (64.4%), onset after 50 years (64.4%). The most specific items were posttraumatic onset of headache (94.5%), neoplasm in history (89.1%) and systemic symptoms (89%). The area under the curve of the SNNOOP10 list was 0.66 (95% CI: 0.55–0.76). Conclusion: The red flags from the SNNOOP10 list showed a 100% sensitivity in the detection of high-risk headache disorders.

AB - Aim: To evaluate the diagnostic accuracy of the SNNOOP10 list in the detection of high-risk headaches. Methods: Patients that visited the Hospital Clínico San Carlos (Madrid) emergency department due to headache that were allocated to a Manchester Triage System level between critical and urgent were prospectively included but retrospectively analysed. A researcher blind to the patients’ diagnosis administered a standardised questionnaire and afterwards a neurologist blind to the questionnaire results diagnosed the patient according to the International Classification of Headache Disorders. The primary endpoint was to assess the sensitivity of the SNNOOP10 list in the detection of high-risk headaches. Secondary endpoints included the evaluation of the sensitivity, specificity, positive predictive value, negative predictive value and area under the curve of each SNNOOP10 item. Results: Between April 2015 and October 2021, 100 patients were included. Patients were 44 years old (inter-quartile range: 33.6–64.7) and 57% were female. We identified 37 different diagnoses. Final diagnosis was a primary headache in 33%, secondary headache in 65% and cranial neuralgia in 2%. There were 46 patients that were considered as having high-risk headache. Patients from the primary headache group were younger and more frequently female. Sensitivity of SNNOOP10 list was 100% (95% confidence interval: 90.2%–100%). The items with higher sensitivity were neurologic deficit or disfunction (75.5%), pattern change or recent onset of the headache (64.4%), onset after 50 years (64.4%). The most specific items were posttraumatic onset of headache (94.5%), neoplasm in history (89.1%) and systemic symptoms (89%). The area under the curve of the SNNOOP10 list was 0.66 (95% CI: 0.55–0.76). Conclusion: The red flags from the SNNOOP10 list showed a 100% sensitivity in the detection of high-risk headache disorders.

KW - cerebrovascular disorders

KW - diagnosis

KW - emergency service

KW - Headache disorders

KW - hospital

KW - neoplasms

KW - secondary

U2 - 10.1177/03331024221120249

DO - 10.1177/03331024221120249

M3 - Journal article

C2 - 36003002

AN - SCOPUS:85136632062

VL - 42

SP - 1521

EP - 1531

JO - Cephalalgia

JF - Cephalalgia

SN - 0800-1952

IS - 14

ER -

ID: 335099014